

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glycosphingolipid catabolic process (GO:0046479) | 5.12268645 |
| 2 | glycolipid catabolic process (GO:0019377) | 4.65692130 |
| 3 | GDP-mannose metabolic process (GO:0019673) | 4.40803166 |
| 4 | oligosaccharide catabolic process (GO:0009313) | 4.19236987 |
| 5 | sperm capacitation (GO:0048240) | 4.12280759 |
| 6 | ceramide catabolic process (GO:0046514) | 4.02833057 |
| 7 | regulation of guanylate cyclase activity (GO:0031282) | 3.85405278 |
| 8 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.83702903 |
| 9 | peptide catabolic process (GO:0043171) | 3.73182179 |
| 10 | intestinal absorption (GO:0050892) | 3.72179471 |
| 11 | bile acid and bile salt transport (GO:0015721) | 3.71498431 |
| 12 | protein carboxylation (GO:0018214) | 3.66749070 |
| 13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.66749070 |
| 14 | sphingolipid catabolic process (GO:0030149) | 3.61634289 |
| 15 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.59704538 |
| 16 | angiotensin maturation (GO:0002003) | 3.59598691 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 3.57302960 |
| 18 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.55427754 |
| 19 | membrane lipid catabolic process (GO:0046466) | 3.44810035 |
| 20 | flavonoid metabolic process (GO:0009812) | 3.37817290 |
| 21 | urea metabolic process (GO:0019627) | 3.34121310 |
| 22 | response to acidic pH (GO:0010447) | 3.30889266 |
| 23 | cellular glucuronidation (GO:0052695) | 3.29993653 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.28570133 |
| 25 | urea cycle (GO:0000050) | 3.28043161 |
| 26 | glucuronate metabolic process (GO:0019585) | 3.18320758 |
| 27 | uronic acid metabolic process (GO:0006063) | 3.18320758 |
| 28 | sexual reproduction (GO:0019953) | 3.15333144 |
| 29 | response to peptidoglycan (GO:0032494) | 3.11980456 |
| 30 | cellular response to pH (GO:0071467) | 3.10526069 |
| 31 | epoxygenase P450 pathway (GO:0019373) | 3.08216027 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.05805290 |
| 33 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.02529781 |
| 34 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.02529781 |
| 35 | regulation of vitamin metabolic process (GO:0030656) | 2.98874245 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 2.97888147 |
| 37 | glutathione biosynthetic process (GO:0006750) | 2.95530137 |
| 38 | hyaluronan catabolic process (GO:0030214) | 2.95365092 |
| 39 | amino sugar catabolic process (GO:0046348) | 2.89332135 |
| 40 | L-phenylalanine metabolic process (GO:0006558) | 2.87269059 |
| 41 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.87269059 |
| 42 | glycoside metabolic process (GO:0016137) | 2.86787500 |
| 43 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.84242105 |
| 44 | ethanol oxidation (GO:0006069) | 2.80948943 |
| 45 | hormone catabolic process (GO:0042447) | 2.77088554 |
| 46 | regulation of cholesterol homeostasis (GO:2000188) | 2.76948339 |
| 47 | regulation of mononuclear cell migration (GO:0071675) | 2.74418953 |
| 48 | glycosylceramide metabolic process (GO:0006677) | 2.72144582 |
| 49 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.71824455 |
| 50 | regulation of respiratory burst (GO:0060263) | 2.70728811 |
| 51 | neutrophil activation involved in immune response (GO:0002283) | 2.68595395 |
| 52 | ketone body metabolic process (GO:1902224) | 2.68561348 |
| 53 | NADH metabolic process (GO:0006734) | 2.67023615 |
| 54 | adenosine receptor signaling pathway (GO:0001973) | 2.66954794 |
| 55 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.66795742 |
| 56 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.65709030 |
| 57 | endocrine process (GO:0050886) | 2.65709030 |
| 58 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.65709030 |
| 59 | positive regulation of respiratory burst (GO:0060267) | 2.64542261 |
| 60 | sphingomyelin metabolic process (GO:0006684) | 2.64132918 |
| 61 | complement activation, alternative pathway (GO:0006957) | 2.62354704 |
| 62 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.62329119 |
| 63 | renal system process involved in regulation of blood volume (GO:0001977) | 2.61296213 |
| 64 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.61146446 |
| 65 | glutathione metabolic process (GO:0006749) | 2.58737362 |
| 66 | N-acetylneuraminate metabolic process (GO:0006054) | 2.58321059 |
| 67 | bile acid metabolic process (GO:0008206) | 2.58229308 |
| 68 | protein retention in ER lumen (GO:0006621) | 2.57838601 |
| 69 | response to thyroid hormone (GO:0097066) | 2.57641156 |
| 70 | cellular ketone body metabolic process (GO:0046950) | 2.55569552 |
| 71 | drug transport (GO:0015893) | 2.53339957 |
| 72 | plasma membrane fusion (GO:0045026) | 2.52536210 |
| 73 | immunoglobulin mediated immune response (GO:0016064) | 2.52245754 |
| 74 | barbed-end actin filament capping (GO:0051016) | 2.52082439 |
| 75 | drug transmembrane transport (GO:0006855) | 2.51358640 |
| 76 | transcytosis (GO:0045056) | 2.50901842 |
| 77 | detection of molecule of bacterial origin (GO:0032490) | 2.50787959 |
| 78 | acrosome reaction (GO:0007340) | 2.49892606 |
| 79 | glomerular filtration (GO:0003094) | 2.49560766 |
| 80 | alkaloid metabolic process (GO:0009820) | 2.48877723 |
| 81 | melanin biosynthetic process (GO:0042438) | 2.48453135 |
| 82 | low-density lipoprotein particle clearance (GO:0034383) | 2.47088141 |
| 83 | negative regulation of interleukin-8 production (GO:0032717) | 2.46782252 |
| 84 | regulation of cGMP biosynthetic process (GO:0030826) | 2.46689800 |
| 85 | fibrinolysis (GO:0042730) | 2.45285805 |
| 86 | renal filtration (GO:0097205) | 2.45098848 |
| 87 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.44717216 |
| 88 | response to pH (GO:0009268) | 2.43242736 |
| 89 | positive regulation of pseudopodium assembly (GO:0031274) | 2.40859068 |
| 90 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.40087494 |
| 91 | drug metabolic process (GO:0017144) | 2.36791407 |
| 92 | pinocytosis (GO:0006907) | 2.35886520 |
| 93 | sperm motility (GO:0030317) | 2.35720894 |
| 94 | regulation of metalloenzyme activity (GO:0048552) | 2.34041988 |
| 95 | regulation of cholesterol esterification (GO:0010872) | 2.33463544 |
| 96 | mannose metabolic process (GO:0006013) | 2.33363199 |
| 97 | phospholipid efflux (GO:0033700) | 2.33215936 |
| 98 | regulation of cellular pH (GO:0030641) | 2.32727800 |
| 99 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.32463771 |
| 100 | negative regulation of blood coagulation (GO:0030195) | 2.32326144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.20351014 |
| 2 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.87755437 |
| 3 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.56989182 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.56144378 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.53149726 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.46271105 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.44302409 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.44263817 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.41923603 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.41162484 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.28109235 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.12037743 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.11172229 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.08467624 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.07848739 |
| 16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.94545537 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.94070035 |
| 18 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.92551013 |
| 19 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.90065076 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.88798123 |
| 21 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.88285097 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.87758650 |
| 23 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.81947468 |
| 24 | P68_20966046_ChIP-Seq_HELA_Human | 1.70468491 |
| 25 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.69696143 |
| 26 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.69551821 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.65939857 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.62360499 |
| 29 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.61904203 |
| 30 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.61648025 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.59704359 |
| 32 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.58736577 |
| 33 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.55647732 |
| 34 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.54842146 |
| 35 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.50056882 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.46818645 |
| 37 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.44866144 |
| 38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44091752 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42360922 |
| 40 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.41718542 |
| 41 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41387632 |
| 42 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40220143 |
| 43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39115887 |
| 44 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38961135 |
| 45 | ATF3_27146783_Chip-Seq_COLON_Human | 1.38870062 |
| 46 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.37499192 |
| 47 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.37482665 |
| 48 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.36533167 |
| 49 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.36440907 |
| 50 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.36190277 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34981608 |
| 52 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.34869121 |
| 53 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.33990579 |
| 54 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.30888178 |
| 55 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.30879328 |
| 56 | SA1_27219007_Chip-Seq_Bcells_Human | 1.30599613 |
| 57 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.30362311 |
| 58 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29974464 |
| 59 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.26166585 |
| 60 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23608744 |
| 61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23495547 |
| 62 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21635326 |
| 63 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.21357701 |
| 64 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.20818854 |
| 65 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20134767 |
| 66 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.19997961 |
| 67 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.19715609 |
| 68 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.19463622 |
| 69 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.19274885 |
| 70 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.19052163 |
| 71 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18322589 |
| 72 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17961453 |
| 73 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.17859780 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16020793 |
| 75 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.15952738 |
| 76 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.15764970 |
| 77 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.15534546 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14215378 |
| 79 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.13183391 |
| 80 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.12441263 |
| 81 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10973935 |
| 82 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.09186654 |
| 83 | P300_27268052_Chip-Seq_Bcells_Human | 1.09095050 |
| 84 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.08687475 |
| 85 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.08278051 |
| 86 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.07883672 |
| 87 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.06702138 |
| 88 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.06200471 |
| 89 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05329531 |
| 90 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04972134 |
| 91 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04866440 |
| 92 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04605611 |
| 93 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.04362301 |
| 94 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.04161280 |
| 95 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02864135 |
| 96 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.02322751 |
| 97 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.02315067 |
| 98 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.01840552 |
| 99 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01563705 |
| 100 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01407452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.55491609 |
| 2 | MP0005360_urolithiasis | 3.73201124 |
| 3 | MP0005365_abnormal_bile_salt | 3.55969893 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.37451389 |
| 5 | MP0009840_abnormal_foam_cell | 3.15006991 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.02847839 |
| 7 | MP0005410_abnormal_fertilization | 2.84767445 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.78611058 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.34022607 |
| 10 | MP0005451_abnormal_body_composition | 2.31540021 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.21589158 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.20450703 |
| 13 | MP0006082_CNS_inflammation | 2.10196528 |
| 14 | MP0005257_abnormal_intraocular_pressure | 2.08997623 |
| 15 | MP0005171_absent_coat_pigmentation | 2.05595933 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.03007934 |
| 17 | MP0005670_abnormal_white_adipose | 2.02941131 |
| 18 | MP0003303_peritoneal_inflammation | 1.90672212 |
| 19 | MP0001666_abnormal_nutrient_absorption | 1.86619506 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 1.77542119 |
| 21 | MP0003436_decreased_susceptibility_to | 1.76413504 |
| 22 | MP0009785_altered_susceptibility_to | 1.68883305 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.65456930 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.58556626 |
| 25 | MP0005409_darkened_coat_color | 1.58156281 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.54610869 |
| 27 | MP0003724_increased_susceptibility_to | 1.51793944 |
| 28 | MP0003453_abnormal_keratinocyte_physiol | 1.44939830 |
| 29 | MP0002419_abnormal_innate_immunity | 1.40454133 |
| 30 | MP0005083_abnormal_biliary_tract | 1.38590226 |
| 31 | MP0005166_decreased_susceptibility_to | 1.38127108 |
| 32 | MP0004264_abnormal_extraembryonic_tissu | 1.37930436 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.32920353 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.32710692 |
| 35 | MP0005025_abnormal_response_to | 1.31803761 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.29513547 |
| 37 | MP0005332_abnormal_amino_acid | 1.26030239 |
| 38 | MP0001756_abnormal_urination | 1.25173318 |
| 39 | MP0000343_altered_response_to | 1.23772596 |
| 40 | MP0008469_abnormal_protein_level | 1.22346666 |
| 41 | MP0010329_abnormal_lipoprotein_level | 1.21680717 |
| 42 | MP0005377_hearing/vestibular/ear_phenot | 1.21670584 |
| 43 | MP0003878_abnormal_ear_physiology | 1.21670584 |
| 44 | MP0005310_abnormal_salivary_gland | 1.19267125 |
| 45 | MP0005408_hypopigmentation | 1.17454552 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 1.16587528 |
| 47 | MP0001765_abnormal_ion_homeostasis | 1.15792623 |
| 48 | MP0000678_abnormal_parathyroid_gland | 1.15366499 |
| 49 | MP0001663_abnormal_digestive_system | 1.15257245 |
| 50 | MP0005174_abnormal_tail_pigmentation | 1.14140328 |
| 51 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13917051 |
| 52 | MP0000858_altered_metastatic_potential | 1.12849748 |
| 53 | MP0000609_abnormal_liver_physiology | 1.11905722 |
| 54 | MP0002118_abnormal_lipid_homeostasis | 1.11752434 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.11375361 |
| 56 | MP0003075_altered_response_to | 1.11089056 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.09897172 |
| 58 | MP0003868_abnormal_feces_composition | 1.08090318 |
| 59 | MP0003866_abnormal_defecation | 1.07939908 |
| 60 | MP0009764_decreased_sensitivity_to | 1.05366369 |
| 61 | MP0000604_amyloidosis | 1.03556039 |
| 62 | MP0003950_abnormal_plasma_membrane | 1.02357281 |
| 63 | MP0001764_abnormal_homeostasis | 1.02134053 |
| 64 | MP0005319_abnormal_enzyme/_coenzyme | 1.01104649 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.00679540 |
| 66 | MP0000490_abnormal_crypts_of | 0.98818343 |
| 67 | MP0000015_abnormal_ear_pigmentation | 0.96659103 |
| 68 | MP0004782_abnormal_surfactant_physiolog | 0.96109156 |
| 69 | MP0002136_abnormal_kidney_physiology | 0.95329496 |
| 70 | MP0001664_abnormal_digestion | 0.93027727 |
| 71 | MP0005387_immune_system_phenotype | 0.92356253 |
| 72 | MP0001790_abnormal_immune_system | 0.92356253 |
| 73 | MP0002452_abnormal_antigen_presenting | 0.90474681 |
| 74 | MP0001835_abnormal_antigen_presentation | 0.89434847 |
| 75 | MP0005636_abnormal_mineral_homeostasis | 0.89355969 |
| 76 | MP0000371_diluted_coat_color | 0.88794658 |
| 77 | MP0005165_increased_susceptibility_to | 0.88379537 |
| 78 | MP0001873_stomach_inflammation | 0.88202389 |
| 79 | MP0005023_abnormal_wound_healing | 0.87949368 |
| 80 | MP0000685_abnormal_immune_system | 0.87437109 |
| 81 | MP0001853_heart_inflammation | 0.87260968 |
| 82 | MP0005164_abnormal_response_to | 0.86314434 |
| 83 | MP0001661_extended_life_span | 0.86238248 |
| 84 | MP0002132_abnormal_respiratory_system | 0.85891274 |
| 85 | MP0005381_digestive/alimentary_phenotyp | 0.84583703 |
| 86 | MP0003448_altered_tumor_morphology | 0.84566971 |
| 87 | MP0004947_skin_inflammation | 0.84334499 |
| 88 | MP0009333_abnormal_splenocyte_physiolog | 0.83449702 |
| 89 | MP0005330_cardiomyopathy | 0.79839144 |
| 90 | MP0008260_abnormal_autophagy | 0.79588390 |
| 91 | MP0002723_abnormal_immune_serum | 0.79536246 |
| 92 | MP0005000_abnormal_immune_tolerance | 0.79175932 |
| 93 | MP0003252_abnormal_bile_duct | 0.78736081 |
| 94 | MP0000249_abnormal_blood_vessel | 0.78523409 |
| 95 | MP0000372_irregular_coat_pigmentation | 0.77040605 |
| 96 | MP0005666_abnormal_adipose_tissue | 0.76446987 |
| 97 | MP0000751_myopathy | 0.73846082 |
| 98 | MP0003879_abnormal_hair_cell | 0.70655062 |
| 99 | MP0003828_pulmonary_edema | 0.70312296 |
| 100 | MP0003300_gastrointestinal_ulcer | 0.68927450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.98868476 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.98868476 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.98868476 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 4.67296740 |
| 5 | Hemorrhage of the eye (HP:0011885) | 4.51891208 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.69614479 |
| 7 | Increased cerebral lipofuscin (HP:0011813) | 3.39702415 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 3.31325890 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.29647864 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 3.11574813 |
| 11 | Joint hemorrhage (HP:0005261) | 3.06992615 |
| 12 | Renal Fanconi syndrome (HP:0001994) | 3.01616891 |
| 13 | Hyperactive renin-angiotensin system (HP:0000841) | 3.00176902 |
| 14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.97654967 |
| 15 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.93686731 |
| 16 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.93686731 |
| 17 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.93686731 |
| 18 | Dysostosis multiplex (HP:0000943) | 2.93512248 |
| 19 | Mucopolysacchariduria (HP:0008155) | 2.86823047 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.86823047 |
| 21 | Thin bony cortex (HP:0002753) | 2.86072336 |
| 22 | Complement deficiency (HP:0004431) | 2.82941856 |
| 23 | Deep venous thrombosis (HP:0002625) | 2.75098274 |
| 24 | Petechiae (HP:0000967) | 2.74425859 |
| 25 | Malnutrition (HP:0004395) | 2.70785664 |
| 26 | Abnormality of complement system (HP:0005339) | 2.70661669 |
| 27 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.69210113 |
| 28 | Glomerulonephritis (HP:0000099) | 2.68166240 |
| 29 | Abnormality of macrophages (HP:0004311) | 2.64728657 |
| 30 | Decreased circulating renin level (HP:0003351) | 2.64361866 |
| 31 | Asymmetric septal hypertrophy (HP:0001670) | 2.63836263 |
| 32 | Axonal loss (HP:0003447) | 2.61062556 |
| 33 | Xanthomatosis (HP:0000991) | 2.56568647 |
| 34 | Abdominal distention (HP:0003270) | 2.54468827 |
| 35 | Enlarged epiphyses (HP:0010580) | 2.52420020 |
| 36 | Mesangial abnormality (HP:0001966) | 2.50500743 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.48658746 |
| 38 | Metabolic alkalosis (HP:0200114) | 2.41738172 |
| 39 | Purpura (HP:0000979) | 2.37704964 |
| 40 | Prolonged neonatal jaundice (HP:0006579) | 2.37288736 |
| 41 | Intrahepatic cholestasis (HP:0001406) | 2.36852227 |
| 42 | Loss of speech (HP:0002371) | 2.34979174 |
| 43 | Myocardial infarction (HP:0001658) | 2.34150450 |
| 44 | Hydroxyprolinuria (HP:0003080) | 2.33038253 |
| 45 | Abnormality of proline metabolism (HP:0010907) | 2.33038253 |
| 46 | Widely patent fontanelles and sutures (HP:0004492) | 2.31850284 |
| 47 | Paraparesis (HP:0002385) | 2.31511323 |
| 48 | Nephritis (HP:0000123) | 2.31275771 |
| 49 | Eczematoid dermatitis (HP:0000976) | 2.28851148 |
| 50 | Conjugated hyperbilirubinemia (HP:0002908) | 2.28455539 |
| 51 | Abnormality of renin-angiotensin system (HP:0000847) | 2.26168476 |
| 52 | Ileus (HP:0002595) | 2.24834006 |
| 53 | Glycosuria (HP:0003076) | 2.22919759 |
| 54 | Abnormality of urine glucose concentration (HP:0011016) | 2.22919759 |
| 55 | Abnormality of chloride homeostasis (HP:0011422) | 2.20739834 |
| 56 | Alkalosis (HP:0001948) | 2.19526228 |
| 57 | Recurrent abscess formation (HP:0002722) | 2.16335794 |
| 58 | Abnormality of the costochondral junction (HP:0000919) | 2.16289425 |
| 59 | Severe visual impairment (HP:0001141) | 2.15007021 |
| 60 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.14546164 |
| 61 | Increased muscle lipid content (HP:0009058) | 2.12809966 |
| 62 | Congenital sensorineural hearing impairment (HP:0008527) | 2.10926141 |
| 63 | Increased hepatocellular lipid droplets (HP:0006565) | 2.10221031 |
| 64 | Lipid accumulation in hepatocytes (HP:0006561) | 2.08263629 |
| 65 | Recurrent bacterial skin infections (HP:0005406) | 2.08244553 |
| 66 | Protuberant abdomen (HP:0001538) | 2.07714067 |
| 67 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.06515530 |
| 68 | Generalized aminoaciduria (HP:0002909) | 2.05189876 |
| 69 | Hypobetalipoproteinemia (HP:0003563) | 2.04335952 |
| 70 | Abnormality of the nasal mucosa (HP:0000433) | 2.03251340 |
| 71 | Progressive neurologic deterioration (HP:0002344) | 2.02988394 |
| 72 | Exertional dyspnea (HP:0002875) | 2.02979469 |
| 73 | Hypolipoproteinemia (HP:0010981) | 2.01894344 |
| 74 | Vertebral compression fractures (HP:0002953) | 2.01527029 |
| 75 | Hypoalphalipoproteinemia (HP:0003233) | 2.00871853 |
| 76 | Increased intramyocellular lipid droplets (HP:0012240) | 1.98820113 |
| 77 | Akinesia (HP:0002304) | 1.98778397 |
| 78 | Hypertriglyceridemia (HP:0002155) | 1.97126818 |
| 79 | Bone pain (HP:0002653) | 1.97087774 |
| 80 | Abnormal urine phosphate concentration (HP:0012599) | 1.96242045 |
| 81 | Abnormality of the intrinsic pathway (HP:0010989) | 1.94289127 |
| 82 | Fat malabsorption (HP:0002630) | 1.93904259 |
| 83 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.93760205 |
| 84 | Testicular atrophy (HP:0000029) | 1.93304594 |
| 85 | Choroideremia (HP:0001139) | 1.93212877 |
| 86 | Amyloidosis (HP:0011034) | 1.91940718 |
| 87 | Renal tubular dysfunction (HP:0000124) | 1.91535486 |
| 88 | Hepatosplenomegaly (HP:0001433) | 1.88636892 |
| 89 | Hyperphosphaturia (HP:0003109) | 1.87101241 |
| 90 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.85540234 |
| 91 | Delayed epiphyseal ossification (HP:0002663) | 1.84637638 |
| 92 | Hypophosphatemia (HP:0002148) | 1.83748886 |
| 93 | Attenuation of retinal blood vessels (HP:0007843) | 1.83129675 |
| 94 | Spastic paraparesis (HP:0002313) | 1.81958928 |
| 95 | Disinhibition (HP:0000734) | 1.81130960 |
| 96 | Hyponatremia (HP:0002902) | 1.80812848 |
| 97 | Abnormality of renal resorption (HP:0011038) | 1.79644949 |
| 98 | Nausea (HP:0002018) | 1.78552977 |
| 99 | Increased serum ferritin (HP:0003281) | 1.78418677 |
| 100 | Flattened epiphyses (HP:0003071) | 1.77132690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 8.08829209 |
| 2 | EPHA2 | 3.59515229 |
| 3 | ERN1 | 3.45363852 |
| 4 | IRAK3 | 3.16046171 |
| 5 | MET | 2.94752590 |
| 6 | TESK1 | 2.84857997 |
| 7 | MAPK15 | 2.44225746 |
| 8 | ACVR1B | 2.37357005 |
| 9 | BLK | 2.34451413 |
| 10 | TESK2 | 2.25096371 |
| 11 | LMTK2 | 2.15655278 |
| 12 | DDR2 | 2.13411184 |
| 13 | RIPK1 | 2.08460699 |
| 14 | INSRR | 1.92693875 |
| 15 | NME2 | 1.91320760 |
| 16 | EPHB2 | 1.85276331 |
| 17 | TGFBR2 | 1.78159687 |
| 18 | MAP3K11 | 1.74007962 |
| 19 | MAP3K3 | 1.55686869 |
| 20 | SIK1 | 1.44262472 |
| 21 | PDPK1 | 1.41626670 |
| 22 | PAK4 | 1.38302645 |
| 23 | TBK1 | 1.36815193 |
| 24 | TRIB3 | 1.36784246 |
| 25 | ABL2 | 1.33910610 |
| 26 | PRKG2 | 1.33682384 |
| 27 | ARAF | 1.26910104 |
| 28 | RIPK4 | 1.25915632 |
| 29 | BMX | 1.22554999 |
| 30 | IRAK2 | 1.17214272 |
| 31 | TYK2 | 1.14963476 |
| 32 | MAP3K2 | 1.13156906 |
| 33 | MAP3K12 | 1.12364370 |
| 34 | CSK | 1.10697175 |
| 35 | ZAP70 | 1.09773826 |
| 36 | PTK6 | 1.04290319 |
| 37 | PDK2 | 1.02659561 |
| 38 | MATK | 1.01095960 |
| 39 | MAP2K3 | 0.97953752 |
| 40 | IRAK4 | 0.94490125 |
| 41 | MAP3K1 | 0.85273644 |
| 42 | GRK6 | 0.84246802 |
| 43 | IKBKB | 0.80446982 |
| 44 | PIM2 | 0.80126865 |
| 45 | GRK7 | 0.79763404 |
| 46 | PIK3CA | 0.77344942 |
| 47 | PDK1 | 0.76875442 |
| 48 | MUSK | 0.76122683 |
| 49 | MAP4K1 | 0.74005480 |
| 50 | STK38 | 0.72330240 |
| 51 | MAP3K14 | 0.68601677 |
| 52 | LIMK1 | 0.66667897 |
| 53 | TAOK1 | 0.61476183 |
| 54 | TAOK2 | 0.61176635 |
| 55 | CSF1R | 0.61150338 |
| 56 | MAP2K6 | 0.61057562 |
| 57 | PRPF4B | 0.60661456 |
| 58 | WNK4 | 0.58727116 |
| 59 | FGR | 0.58614813 |
| 60 | MYLK | 0.58182876 |
| 61 | IRAK1 | 0.56753924 |
| 62 | STK24 | 0.52995171 |
| 63 | MOS | 0.52352168 |
| 64 | IKBKE | 0.48176710 |
| 65 | PLK4 | 0.46134687 |
| 66 | RPS6KA2 | 0.44170880 |
| 67 | LYN | 0.42429415 |
| 68 | MST4 | 0.38694054 |
| 69 | MAPK11 | 0.38473181 |
| 70 | STK39 | 0.38080916 |
| 71 | PRKAA2 | 0.36607653 |
| 72 | STK38L | 0.34820323 |
| 73 | CHUK | 0.34083045 |
| 74 | PTK2 | 0.32728609 |
| 75 | MAP3K8 | 0.32541717 |
| 76 | CDC42BPA | 0.32229072 |
| 77 | MAP2K2 | 0.31496510 |
| 78 | PRKCD | 0.31157192 |
| 79 | PAK1 | 0.30042894 |
| 80 | EPHB1 | 0.29120459 |
| 81 | GRK5 | 0.28851448 |
| 82 | SRC | 0.28563142 |
| 83 | MAPKAPK2 | 0.27734250 |
| 84 | CDK12 | 0.27215563 |
| 85 | SIK3 | 0.27203274 |
| 86 | ADRBK1 | 0.26712181 |
| 87 | JAK3 | 0.26402179 |
| 88 | KDR | 0.26309633 |
| 89 | IGF1R | 0.26305291 |
| 90 | KSR2 | 0.25646471 |
| 91 | TRPM7 | 0.24781201 |
| 92 | MAP3K13 | 0.23585547 |
| 93 | MAP4K2 | 0.22265556 |
| 94 | MAPKAPK3 | 0.21716627 |
| 95 | FER | 0.21243960 |
| 96 | SMG1 | 0.20704435 |
| 97 | CAMK2D | 0.20182158 |
| 98 | ILK | 0.19583372 |
| 99 | CDK6 | 0.19555594 |
| 100 | YES1 | 0.18429401 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.48861088 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.29631144 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.75164514 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.37656230 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.29268599 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.23477082 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.13303266 |
| 8 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.12631775 |
| 9 | Mineral absorption_Homo sapiens_hsa04978 | 2.04732992 |
| 10 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.00230620 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 1.99579698 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.90247985 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.89375187 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.86639110 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.86214979 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82647818 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.80568586 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.79090897 |
| 19 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.79076205 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.76448237 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.74231637 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.71440960 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.71356006 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.69202286 |
| 25 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.67303492 |
| 26 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.66223076 |
| 27 | Sulfur relay system_Homo sapiens_hsa04122 | 1.53694800 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.52367723 |
| 29 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.52113190 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.50987116 |
| 31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.41759006 |
| 32 | Galactose metabolism_Homo sapiens_hsa00052 | 1.39562697 |
| 33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.37066000 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.36487489 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.33938970 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.29340356 |
| 37 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.29258907 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.27808884 |
| 39 | Asthma_Homo sapiens_hsa05310 | 1.27649867 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.23244697 |
| 41 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.19167522 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.17160385 |
| 43 | Leishmaniasis_Homo sapiens_hsa05140 | 1.14101560 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13996273 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13945422 |
| 46 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.10524317 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.08396648 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.08340294 |
| 49 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.04127593 |
| 50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.04107698 |
| 51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.99494488 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 0.99130907 |
| 53 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97460853 |
| 54 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.97048580 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92015344 |
| 56 | Tuberculosis_Homo sapiens_hsa05152 | 0.84046509 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 0.82531615 |
| 58 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.80872185 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79359036 |
| 60 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.75852670 |
| 61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.75377033 |
| 62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.72451627 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70912604 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70776976 |
| 65 | Phagosome_Homo sapiens_hsa04145 | 0.69113527 |
| 66 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.67740993 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.65161879 |
| 68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64761053 |
| 69 | Influenza A_Homo sapiens_hsa05164 | 0.64048617 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.62205653 |
| 71 | Legionellosis_Homo sapiens_hsa05134 | 0.60414550 |
| 72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58724629 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.57637275 |
| 74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56303491 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55748065 |
| 76 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.52344242 |
| 77 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51714826 |
| 78 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45683114 |
| 79 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45152862 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.44456196 |
| 81 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44207577 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43407173 |
| 83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42483999 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41974314 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40506819 |
| 86 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.38026706 |
| 87 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37933262 |
| 88 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.37024541 |
| 89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.36398967 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | 0.33535529 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.32636326 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31978135 |
| 93 | Malaria_Homo sapiens_hsa05144 | 0.31972266 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31872104 |
| 95 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29641114 |
| 96 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.29425212 |
| 97 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28905457 |
| 98 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.28445566 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27705342 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.26210584 |

